The Potential use of Dendritic Cell-based Immunotherapy for Treatment of Pancreatic Cancer

E-ISSN： 1875-6115|9|4|191-202

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.9, Iss.4, 2009-12, pp. : 191-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic Cell-based Immunotherapy for the Treatment of Hematological Malignancies

By Büchler Tomas Michalek Jaroslav Kovarova Lucie Musilova Romana Hajek Roman

Hematology, Vol. 8, Iss. 2, 2003-01 ,pp. : 97-104

Maney Publishing

Access to resources Recommend Favorite

Viral vectors for dendritic cell-based immunotherapy

By Jenne L. Schuler G. Steinkasserer A.

Trends in Immunology, Vol. 22, Iss. 2, 2001-02 ,pp. : 102-107

Elsevier

Access to resources Recommend Favorite

Dendritic cell-based cancer immunotherapies

By Fujii Shin-ichiro

Archivum Immunologiae et Therapiae Experimentalis, Vol. 57, Iss. 3, 2009-06 ,pp. : 189-198

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Considerations in Developing Dendritic Cell Vaccine Based Immunotherapy Protocols in Cancer

Current Molecular Medicine, Vol. 9, Iss. 6, 2009-08 ,pp. : 725-731

Bentham Science Publishers

Access to resources Recommend Favorite

Monitoring of CD4⁺ and CD8⁺ T-Cell Responses After Dendritic Cell-Based Immunotherapy Using CFSE Dye Dilution Analysis

By PUTZ THOMAS RAMONER REINHOLD GANDER HUBERT RAHM ANDREA BARTSCH GEORG HÖLTL LORENZ THURNHER MARTIN

Journal of Clinical Immunology, Vol. 24, Iss. 6, 2004-11 ,pp. : 653-663

Springer Publishing Company

Access to resources Recommend Favorite